IN DEVELOPMENT · PODIATRIST-FOUNDED · SYDNEY, AUSTRALIA
Wartova is building a medicated wart-care patch designed by clinicians, made for everyday life, and working towards TGA listing before it reaches pharmacy shelves.
Warts affect one in three Australians at some point. They show up in classrooms, at the pool, on the job. Completely ordinary, but the care options haven't kept up.
Paints and gels that need reapplying every day. Easy to forget, hard to stick with, awkward at work or school.
Freezing stings. Clinic visits cost time and money. Often the treatment feels worse than the wart itself.
No timeline, no way to know if it's working. People are left guessing when to persist and when to see a doctor.
OUR WARTOVA STORY
“I've treated thousands of warts. The process works — when people can actually stick to it.”
Wartova began in a Sydney podiatry clinic, watching the same story on repeat: a good treatment plan, a busy life, and a wart that wins by sheer persistence.
So we built what we wished we could hand every patient: wart care that fits into real life, not the clinic schedule.
Wartova is a therapeutic goods company, and we act like one. Here's the standard we're building ourselves to.
Pursuing listing on the Australian Register of Therapeutic Goods (ARTG) before our first product goes anywhere near a shelf.
Every claim we make will carry its source — the study, the year, the result. If we can't cite it, we won't say it.
Manufactured under GMP (Good Manufacturing Practice) — the same quality system behind your medicine cabinet.
Some warts need a GP or podiatrist, full stop. Our job includes telling you when that's the case — clearly, early.
FOR GPs, PODIATRISTS, PHARMACISTS & PARTNERS
We're building a professional reference group and advisory network ahead of launch. Clinicians and partners who'll review the evidence before launch.
GET EARLY ACCESS
One email at TGA listing, and an optional launch-day alert. No spam. We don't share data — that's not how we operate.